For what it’s worth - and for our purposes it may not be worth much - I went to one of the clinics offering Vavelta. While there, of course I asked about TRC.
I think I can spot dodgy docs and this one I believe was straight, able and respectable. He gave an open and honest appraisal of Vaveleta and told me what he knew about TRC which he would be offering if it worked.
The issue with TRC is variable growth rates to some degree but mainly a problem of density. Currently, cosmetically acceptable levels of hair density were not being achieved. They were working on it, he said, and “if they can can get it to work it should be available in 2 to 5 years.”
He didn’t know about Intercytex not funding research beyond phase 11 trials or about the search for a partner. Partnering and licensing were common in the industry, he said.
The information doesn’t really change much but at least it takes the paranoia and guesswork out of it.